SELLAS Life Sciences Group, Inc. (SLS)
14.32
-1.14
(-7.34%)
USD |
NASDAQ |
Aug 24, 16:00
14.32
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Shareholders Equity (Quarterly) : 137.66M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 137.66M |
| March 31, 2026 | 107.41M |
| December 31, 2025 | 70.87M |
| September 30, 2025 | 45.63M |
| June 30, 2025 | 26.15M |
| March 31, 2025 | 27.76M |
| December 31, 2024 | 9.465M |
| September 30, 2024 | 15.89M |
| June 30, 2024 | 2.913M |
| March 31, 2024 | 9.684M |
| December 31, 2023 | -7.976M |
| September 30, 2023 | -3.827M |
| June 30, 2023 | 4.843M |
| March 31, 2023 | 13.17M |
| December 31, 2022 | 4.851M |
| September 30, 2022 | 12.60M |
| June 30, 2022 | 19.06M |
| March 31, 2022 | 4.025M |
| December 31, 2021 | 20.35M |
| September 30, 2021 | 26.61M |
| June 30, 2021 | 33.42M |
| March 31, 2021 | 28.74M |
| December 31, 2020 | 27.96M |
| September 30, 2020 | 7.948M |
| June 30, 2020 | 3.783M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.062M |
| December 31, 2019 | 6.093M |
| September 30, 2019 | 10.64M |
| June 30, 2019 | 14.34M |
| March 31, 2019 | 2.95M |
| December 31, 2018 | 5.245M |
| September 30, 2018 | 18.46M |
| June 30, 2018 | -2.483M |
| March 31, 2018 | -1.318M |
| December 31, 2017 | 2.07M |
| September 30, 2017 | 14.64M |
| June 30, 2017 | 19.13M |
| March 31, 2017 | 27.19M |
| December 31, 2016 | 28.66M |
| September 30, 2016 | 23.93M |
| June 30, 2016 | 20.32M |
| March 31, 2016 | 12.41M |
| December 31, 2015 | 13.51M |
| September 30, 2015 | 32.42M |
| June 30, 2015 | 49.36M |
| March 31, 2015 | 59.08M |
| December 31, 2014 | 37.06M |
| September 30, 2014 | 30.86M |
| June 30, 2014 | 28.31M |
| March 31, 2014 | 46.50M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Savara, Inc. | 143.66M |
| Lite Strategy, Inc. | 56.84M |
| AbbVie, Inc. | -5.935B |
| Marker Therapeutics, Inc. | 12.17M |
| Rezolute, Inc. | 116.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 145.38M |
| Total Liabilities (Quarterly) | 7.726M |
| Debt to Equity Ratio | 0.0054 |
| Current Ratio | 18.83 |
| Net Debt Paydown Yield | 0.00% |